Related Experiment Video
Updated: Jul 13, 2026
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
1University of California and Veterans Affairs San Diego Health Care System 92161, USA. dporte@ucsd.edu
Diabetes
|March 29, 2001
Summary
Type 2 diabetes involves progressive beta-cell dysfunction, leading to insulin deficiency. Islet amyloid polypeptide (IAPP) deposits contribute to this loss, worsening hyperglycemia despite treatments.
Area of Science:
- Endocrinology and Metabolism
- Cell Biology
- Diabetes Research
Background:
- Type 2 diabetes is marked by gradual beta-cell function decline.
- This loss involves impaired insulin secretion phases and glucose potentiation.
- Observed beta-cell loss exceeds that explained by cell death alone.
Purpose of the Study:
- To review the role of amyloid deposition in beta-cell dysfunction and failure.
- To explore the association between islet amyloid polypeptide (IAPP) and hyperproinsulinemia.
- To hypothesize the timing and mechanism of IAPP amyloid formation in diabetes progression.
Main Methods:
- Review of existing literature on beta-cell function in type 2 diabetes.
- Analysis of studies on islet amyloid deposits and their functional impact.
- Examination of data from IAPP transgenic mouse models of diabetes.
Main Results:
- Amyloid deposits in islets are linked to disproportionate hyperproinsulinemia.
- Amyloid fibril formation appears to impair beta-cell function early.
- IAPP transgenic mice develop islet amyloid deposits and hyperglycemia.
Conclusions:
- Amyloid fibril formation is implicated in early functional impairment and late beta-cell failure.
- The process of amyloid deposition contributes to progressive hyperglycemia in type 2 diabetes.
- Targeting amyloid formation may offer new therapeutic strategies for type 2 diabetes.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.